UnknownPhase 4NCT03188471

Preventive Application of GnRH Antagonist on Early OHSS

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Principal Investigator: Qingyun Mai
Center for Reproductive Medicine and Department of Gynecology & Obstetrics, First Affiliated Hospital, Sun Yat-sen University
Intervention: GnRH antagonist(drug)
Enrollment: 175 target
Eligibility: 18-45 years · FEMALE
Timeline: 2017 – 2018

Study locations (1)

The First Affiliated Hospital of Sun Yatsen University, Guangzhou, Guangdong, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03188471 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials